DNDN
DNDN Articles
(ASD) American Standard is reaffirming guidance.(AT) Alltel agreed to a $27.5 Billion buyout offer, or $71.50 per share.(CATT) Catapult believes it will miss its earnings estimates for the...
Published:
At about 5:20 this morning after rolling the calendar a day over to see the notes, something stood out like a sore thumb: DENDREON DO OR DIE DATE! The truth is that the May 15 date was on the "by...
Published:
Last Updated:
(AAPL) Apple’s talks about the Beatles are reportedly close to being settled.(ALL) Allstate is going to stop selling homeowners insurance policies in California.(ALU) Alcatel-Lucent earnings came...
Published:
Dendreon hosted a painful conference call today, and despite management answering most questions you could hear some frustration and disappointment out of management. The FDA has requested...
Published:
Stock Tickers: CSCO, DNDN, CMGI, IBM, ISIS, RTP, FWLT, MVSN, TXN, ERTS So far this is turning out to be an interesting day, despite what looks to be very mixed and dull markets ahead of a Fed meeting...
Published:
Dendreon (DNDN-NASDAQ) has already been noted as a bust this morning by us and by everyone else. Even the Sub-Saharan Africa nations have noticed it, and this 10-point drop in the stock may force...
Published:
Dendreon Corporation (DNDN-NASDAQ) was hammered this morning. It received a Complete Response Letter from the FDA that is the equivalent of an "approvable letter" with a request for additional...
Published:
Last Updated:
A.G.Edwards has initiated the recently volatile and controversial Dendreon (DNDN-NASDAQ) with a Hold/Speculative rating. The summary points are that it is starting the biotech as a Hold rated stock...
Published:
Last Updated:
Dendreon’s short interest actually grew again in April from 26.4 million shares in March to 33.9 million shares. The short interest was listed as 16.8 million shares in February. That is almost...
Published:
Last Updated:
Vertex (VRTX-NASDAQ) is seeing quite a bit of trading today ahead of a data presentation tomorrow. This one may have been very active all on its own, but since Dendreon (DNDN-NASDAQ) made its...
Published:
Last Updated:
Cell Genesys, Inc. (CEGE-NASDAQ) has done what many small biotechs do that are in need of cash: sell shares in a private placement "PIPE" after a sharp stock run-up. It has entered into definitive...
Published:
Cramer in a question from a student tonight on CNBC’s MAD MONEY was actually asked about the recently wild Dendreon (DNDN-NASDAQ). What he said was that he thinks it can still go up and that it...
Published: